CYP2C9 c.274G>C ;(p.E92Q)

Variant ID: 10-96701720-G-C

NM_000771.3(CYP2C9):c.274G>C;(p.E92Q)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma.

Nature Communications
Vo, Josh N JN; Wu, Yi-Mi YM; Mishler, Jeanmarie J; Hall, Sarah S; Mannan, Rahul R; Wang, Lisha L; Ning, Yu Y; Zhou, Jin J; Hopkins, Alexander C AC; Estill, James C JC; Chan, Wallace K B WKB; Yesil, Jennifer J; Cao, Xuhong X; Rao, Arvind A; Tsodikov, Alexander A; Talpaz, Moshe M; Cole, Craig E CE; Ye, Jing C JC; , ; Bergsagel, P Leif PL; Auclair, Daniel D; Cho, Hearn Jay HJ; Robinson, Dan R DR; Chinnaiyan, Arul M AM
Publication Date: 2022-06-29

Variant appearance in text: CYP2C9: 274G>C; Glu92Gln
PubMed Link: 35768438
Variant Present in the following documents:
  • 41467_2022_31430_MOESM4_ESM.xlsx, sheet 1
View BVdb publication page



Once-Daily, Single-Tablet Regimens For the Treatment of HIV-1 Infection.

P & T : A Peer-Reviewed Journal For Formulary Management
Truong, William R WR; Schafer, Jason J JJ; Short, William R WR
Publication Date: 2015-01

Variant appearance in text: CYP2C9: E92Q
PubMed Link: 25628507
Variant Present in the following documents:
  • Main text
View BVdb publication page